qPCR and dPCR Instrumentation

qPCR and dPCR Instrumentation

Global qPCR and dPCR Instrumentation Market to Reach US$13.5 Billion by 2030

The global market for qPCR and dPCR Instrumentation estimated at US$7.5 Billion in the year 2023, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. qPCR and dPCR Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$7.3 Billion by the end of the analysis period. Growth in the qPCR and dPCR Instruments segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 11.4% CAGR

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global qPCR and dPCR Instrumentation Market - Key Trends & Drivers Summarized

Quantitative PCR (qPCR) and digital PCR (dPCR) instrumentation are critical tools in molecular biology, enabling precise and accurate quantification of nucleic acids in various applications. qPCR, also known as real-time PCR, measures the accumulation of DNA during the PCR process in real-time, allowing for the quantification of specific DNA sequences. This technique is widely used in diagnostics, gene expression analysis, and pathogen detection due to its sensitivity, specificity, and ability to provide quantitative data. dPCR, on the other hand, partitions a sample into thousands of individual reactions, providing absolute quantification of DNA without the need for standard curves. This method is particularly advantageous for detecting low-abundance targets and analyzing complex mixtures, making it highly valuable in clinical diagnostics, genetic research, and environmental testing.

Technological advancements have significantly enhanced the performance and capabilities of qPCR and dPCR instruments. Modern qPCR systems feature advanced thermal cyclers, highly sensitive optical detection systems, and user-friendly software that streamline data analysis. These instruments are designed for high throughput, enabling simultaneous analysis of multiple samples and reducing the time required for experiments. Additionally, the development of multiplexing capabilities allows for the detection of several targets in a single reaction, increasing the efficiency and cost-effectiveness of qPCR assays. dPCR technology has also evolved, with innovations such as microfluidic platforms and droplet-based systems that enhance partitioning accuracy and reproducibility. These advancements have expanded the applications of dPCR, enabling more precise quantification of rare mutations, copy number variations, and pathogen loads.

The growth in the qPCR and dPCR instrumentation market is driven by several factors. The increasing demand for accurate and rapid diagnostic tools in the healthcare sector is a primary driver, particularly in the wake of the COVID-19 pandemic, which underscored the need for reliable nucleic acid testing. The rise in genetic research and personalized medicine is also propelling market growth, as qPCR and dPCR are essential for gene expression analysis, mutation detection, and biomarker discovery. Technological advancements, including the development of more sensitive and high-throughput instruments, are attracting researchers and clinicians seeking to improve their analytical capabilities. Furthermore, the expansion of applications in agriculture, food safety, and environmental monitoring is boosting the adoption of these technologies. Government funding and investments in genomic research and public health initiatives are further supporting market growth. These factors, combined with continuous innovation and the integration of automated and digital solutions, are expected to drive sustained growth in the qPCR and dPCR instrumentation market in the coming years.

Select Competitors (Total 74 Featured) -

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Asuragen, Inc.
• Analytik Jena AG
• Biocartis NV
• Biotecon Diagnostics GmbH
• BioFire Diagnostics LLC
• Alifax SpA
• Anitoa Systems LLC
• AB ANALITICA s.r.l.
• Bio Molecular Systems

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.